127 related articles for article (PubMed ID: 38613778)
21. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
[TBL] [Abstract][Full Text] [Related]
22. The P2X7 receptor is not essential for development of imiquimod-induced psoriasis-like inflammation in mice.
Geraghty NJ; Mansfield KJ; Fuller SJ; Watson D; Sluyter R
Purinergic Signal; 2017 Dec; 13(4):405-415. PubMed ID: 28597172
[TBL] [Abstract][Full Text] [Related]
23. Cornulin Is Induced in Psoriasis Lesions and Promotes Keratinocyte Proliferation via Phosphoinositide 3-Kinase/Akt Pathways.
Li C; Xiao L; Jia J; Li F; Wang X; Duan Q; Jing H; Yang P; Chen C; Wang Q; Liu J; Shao Y; Wang N; Zheng Y
J Invest Dermatol; 2019 Jan; 139(1):71-80. PubMed ID: 30009832
[TBL] [Abstract][Full Text] [Related]
24. Imiquimod Increases Cutaneous VEGF Expression in Imiquimod-induced Psoriatic Mouse Model.
Wu HH; Xie WL; Zhao YK; Liu JH; Luo DQ
Curr Vasc Pharmacol; 2016; 14(3):275-9. PubMed ID: 26733387
[TBL] [Abstract][Full Text] [Related]
25. Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes.
Stjernholm T; Ommen P; Langkilde A; Johansen C; Iversen L; Rosada C; Stenderup K
Exp Dermatol; 2017 Apr; 26(4):338-345. PubMed ID: 27488462
[TBL] [Abstract][Full Text] [Related]
26. Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1/ERK1/2 pathway.
Li X; Xie X; Zhang L; Meng Y; Li N; Wang M; Zhai C; Liu Z; Di T; Zhang L; Li P
Life Sci; 2019 Feb; 219():311-321. PubMed ID: 30658103
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometry analysis of the subpopulations of mouse keratinocytes and skin immune cells.
Sakamoto K; Goel S; Funakoshi A; Honda T; Nagao K
STAR Protoc; 2022 Mar; 3(1):101052. PubMed ID: 34977690
[TBL] [Abstract][Full Text] [Related]
28. Albendazole negatively regulates keratinocyte proliferation.
Di Fusco D; Stolfi C; Di Grazia A; Dinallo V; Laudisi F; Marafini I; Colantoni A; Monteleone I; Monteleone G
Clin Sci (Lond); 2020 Apr; 134(7):907-920. PubMed ID: 32236445
[TBL] [Abstract][Full Text] [Related]
29. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
Front Immunol; 2021; 12():635076. PubMed ID: 34025642
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of Wilms' tumor 1 in skin lesions of psoriasis is associated with abnormal proliferation and apoptosis of keratinocytes.
Wu R; Liao Y; Shen W; Liu Y; Zhang J; Zheng M; Chen G; Su Y; Zhao M; Lu Q
Mol Med Rep; 2018 Oct; 18(4):3973-3982. PubMed ID: 30132523
[TBL] [Abstract][Full Text] [Related]
31. C10orf99 contributes to the development of psoriasis by promoting the proliferation of keratinocytes.
Chen C; Wu N; Duan Q; Yang H; Wang X; Yang P; Zhang M; Liu J; Liu Z; Shao Y; Zheng Y
Sci Rep; 2018 Jun; 8(1):8590. PubMed ID: 29872130
[TBL] [Abstract][Full Text] [Related]
32. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis.
Schaper K; Dickhaut J; Japtok L; Kietzmann M; Mischke R; Kleuser B; Bäumer W
J Dermatol Sci; 2013 Jul; 71(1):29-36. PubMed ID: 23643308
[TBL] [Abstract][Full Text] [Related]
33. Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod-induced psoriasis.
Sumida H; Yanagida K; Kita Y; Abe J; Matsushima K; Nakamura M; Ishii S; Sato S; Shimizu T
J Immunol; 2014 May; 192(9):4361-9. PubMed ID: 24663678
[TBL] [Abstract][Full Text] [Related]
34. Topical application of imatinib mesylate ameliorated psoriasis-like skin lesions in imiquimod-induced murine model via angiogenesis inhibition.
Hayakawa K; Maeda T; Egusa C; Okubo Y; Harada K
Exp Dermatol; 2023 Jun; 32(6):878-888. PubMed ID: 36928929
[TBL] [Abstract][Full Text] [Related]
35. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R
Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282
[TBL] [Abstract][Full Text] [Related]
36. IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions.
Shibata S; Tada Y; Asano Y; Yanaba K; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S
J Invest Dermatol; 2013 Feb; 133(2):479-88. PubMed ID: 22951728
[TBL] [Abstract][Full Text] [Related]
37. Ginsenoside compound K ameliorates imiquimod-induced psoriasis-like dermatitis through inhibiting REG3A/RegIIIγ expression in keratinocytes.
Fan H; Wang Y; Zhang X; Chen J; Zhou Q; Yu Z; Chen Y; Chen Z; Gu J; Shi Y
Biochem Biophys Res Commun; 2019 Aug; 515(4):665-671. PubMed ID: 31182284
[TBL] [Abstract][Full Text] [Related]
38. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
39. Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model.
Palombo R; Savini I; Avigliano L; Madonna S; Cavani A; Albanesi C; Mauriello A; Melino G; Terrinoni A
Cell Death Dis; 2016 Aug; 7(8):e2344. PubMed ID: 27537526
[TBL] [Abstract][Full Text] [Related]
40. IL-23- and Imiquimod-Induced Models of Experimental Psoriasis in Mice.
Singh TP; Zhang HH; Hwang ST; Farber JM
Curr Protoc Immunol; 2019 Jun; 125(1):e71. PubMed ID: 30615272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
